Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 635

1.

Medicine. What are the right targets for psychopharmacology?

Hyman SE, Fenton WS.

Science. 2003 Jan 17;299(5605):350-1. No abstract available.

PMID:
12532001
2.

Cognitive neuroscience and schizophrenia: translational research in need of a translator.

Cohen JD, Insel TR.

Biol Psychiatry. 2008 Jul 1;64(1):2-3. doi: 10.1016/j.biopsych.2008.04.031. No abstract available.

PMID:
18549873
3.

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.

PMID:
18172019
4.

Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.

PMID:
18172017
5.

Psychopharmacology in the mentally retarded and a few related issues.

Gualtieri CT, Keppel JM.

Psychopharmacol Bull. 1985;21(2):304-9. Review. No abstract available.

PMID:
2860694
6.

The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993.

Haigler HJ.

Psychopharmacol Bull. 1994;30(1):19-22. Review. No abstract available.

PMID:
7972624
7.

[Multicenter psychopharmacologic research and the data bank].

Cassano GB, Conti L, Massimetti G.

Acta Psychiatr Belg. 1983 May-Jun;83(3):267-81. French.

PMID:
6356790
8.

Drug initiatives to improve cognitive function.

Marder SR.

J Clin Psychiatry. 2006;67 Suppl 9:31-5; discussion 36-42.

9.

The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.

Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):214-20. doi: 10.1176/appi.ajp.2007.07010043. Epub 2008 Jan 2.

PMID:
18172018
10.

Psychopharmacology. The medication merry-go-round.

Brown K.

Science. 2003 Mar 14;299(5613):1646-9. No abstract available.

PMID:
12637713
11.

Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders.

Ban TA.

Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(5):527-80. Review. No abstract available.

PMID:
2892227
12.

The MATRICS consensus cognitive battery: what we know 6 years later.

Green MF, Harris JG, Nuechterlein KH.

Am J Psychiatry. 2014 Nov 1;171(11):1151-4. doi: 10.1176/appi.ajp.2014.14070936. No abstract available.

PMID:
25756630
13.

[Methodological approaches to the assessment of cognitive symptoms during psychopharmacotherapy].

Tsygankov BD, Khananova AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(10):66-71. Review. Russian. No abstract available.

PMID:
21510452
14.

Medication development and testing in children and adolescents. Current problems, future directions.

Vitiello B, Jensen PS.

Arch Gen Psychiatry. 1997 Sep;54(9):871-6. Review.

PMID:
9294379
15.

Pharmacological enhancement of cognition in individuals with schizophrenia.

Lewis DA.

Biol Psychiatry. 2011 Mar 1;69(5):397-8. doi: 10.1016/j.biopsych.2011.01.001. No abstract available.

PMID:
21316514
16.

[Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry].

Saletu B.

Bibl Psychiatr. 1976;(155):1-245. Review. German. No abstract available.

PMID:
802167
17.

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR.

Biol Psychiatry. 2004 Sep 1;56(5):301-7. Review.

PMID:
15336511
18.
19.

Stimulating the development of drug treatments to improve cognition in schizophrenia.

Green MF.

Annu Rev Clin Psychol. 2007;3:159-80. Review.

PMID:
17716052
20.

Lessons from MATRICS.

Marder SR.

Schizophr Bull. 2011 Mar;37(2):233-4. doi: 10.1093/schbul/sbq166. Epub 2011 Feb 16. No abstract available.

Supplemental Content

Support Center